Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-11

Clinical Trial Update: Understanding and Treating Suicidal Ideation With Ketamine [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update indicates ketamine is being studied in Phase 2 and Phase 3 trials for suicidal ideation and major depressive disorder, currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: The Royal's Institute of Mental Health Research | Conditions: Suicidal Ideation, Major Depressive Disorder (MDD) | Phase 2, Phase 3 | Status: RECRUITING